CytomX Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CTMX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 20.73 M19.91 M21.04 M15.75 M15.55 M 72.25 M Cash from investing activities 18.17 M15.13 M30.6 M15.17 M-439 K 60.46 M Cash from financing activities 02.25 M093.55 M253 K 96.05 M Free cash flow 20.71 M19.83 M20.92 M15.73 M15.68 M 72.15 M

Haberler

NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates

CytomX Guggenheim Zirvesi’nde: Umut Verici Kolorektal Kanser Tedavi Yolu

CytomX at Guggenheim Summit: Promising CRC Treatment Path

Qiagen (QGEN) Meets Q4 Earnings Estimates

CytomX Therapeutics stock hits 52-week high at 6.16 USD

Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?

Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?

Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data

CytomX Stock Rises 31% in a Month: Here's What You Should Know

CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX)